Stryker launches national direct-to-patient marketing campaign
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/24/2026
- Wall Street ends down as oil prices, Treasury yields rise
- BTIG’s Krinsky warns 2000-like signals are mounting
- HSBC remains max bullish on stocks, tells investors to lean into tech
- Analyst explains why the midterm outcome is a “fundamental non-event”
- Oil settles up around 4% as Iran's president vows to never surrender
- Wall Street ends down as oil prices, Treasury yields rise
- Anthropic's Claude AI identifies novel enzyme system in DNA search
- AppLovin (APP) on watch amid 3% drop premarket as boutique comments circulate
- Plug Power COO resigns to join another company
- Xtend AI Robotics wins Phase III of USSOCOM lethal drone program
Stryker (SYK) PT Raised to $310 at Oppenheimer
August 4, 2023 8:34 AM EDTOppenheimer analyst Steven Lichtman raised the price target on Stryker (NYSE: SYK) to $310.00 (from $305.00) while maintaining a Outperform rating following earnings.
The analyst commented, "SYK's 2Q23 sales of $4.996B (+11.9% organic) beat our/Street's ~$4.843B/$4.826BE. Outperformance was broad-based with particular standouts being Hips,... More
